Costa Rica vs Japan: Communicable diseases — Communicable disease incidence
Communicable diseases — Communicable disease incidence over time
- Costa Rica
- Japan
How they compare
Costa Rica currently reports 1,074 Cases against 332 Cases in Japan, a difference of 742 Cases.
That makes Costa Rica's figure about 3.2 times Japan's.
The two have swapped places 6 times across 32 shared years of data; in 1993 it was Costa Rica ahead.
Costa Rica ranks 8th and Japan ranks 11th of 34 countries.
Across the 4 decades both report, Costa Rica averaged higher in 3 and Japan in 1.
Head to head by decade
| Decade | Costa Rica | Japan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 202.86 Cases | 201 Cases | 1.86 Cases | Costa Rica |
| 2000s | 259.7 Cases | 374.3 Cases | 114.6 Cases | Japan |
| 2010s | 834.9 Cases | 431.6 Cases | 403.3 Cases | Costa Rica |
| 2020s | 874.2 Cases | 307 Cases | 567.2 Cases | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher communicable diseases — communicable disease incidence, Costa Rica or Japan?
- Costa Rica, at 1,074 Cases against 332 Cases in Japan as of 2025.
- What is the difference in communicable diseases — communicable disease incidence between Costa Rica and Japan?
- 742 Cases, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Japan?
- 32 years are reported by both, from 1993 to 2024.
- How do Costa Rica and Japan rank globally for communicable diseases — communicable disease incidence?
- Costa Rica ranks 8th and Japan ranks 11th of 34 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Communicable diseases — Communicable disease incidence. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents time series on Acquired Immunodeficiency Syndrome (AIDS), for the number of AIDS cases and incidence rates per 100 000 population at year of diagnosis. It also includes data on incidence of pertussis, measles, and hepatitis B, in terms of rates of reported cases per 100 000 population. Please refer to the Sources and Methods for detailed country-specific information.